Westpac Banking Corp decreased its holdings in shares of Aetna Inc (NYSE:AET) by 17.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 47,026 shares of the company’s stock after selling 9,700 shares during the quarter. Westpac Banking Corp’s holdings in Aetna were worth $8,483,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also made changes to their positions in the company. Janus Henderson Group PLC grew its stake in Aetna by 9,446.2% in the 2nd quarter. Janus Henderson Group PLC now owns 4,328,900 shares of the company’s stock valued at $657,255,000 after buying an additional 4,283,553 shares during the last quarter. Capital World Investors grew its stake in Aetna by 8.9% in the 2nd quarter. Capital World Investors now owns 20,769,004 shares of the company’s stock valued at $3,153,358,000 after buying an additional 1,688,767 shares during the last quarter. Orbimed Advisors LLC grew its stake in Aetna by 57.3% in the 3rd quarter. Orbimed Advisors LLC now owns 1,396,500 shares of the company’s stock valued at $222,057,000 after buying an additional 508,600 shares during the last quarter. Samlyn Capital LLC acquired a new position in Aetna in the 2nd quarter valued at $77,170,000. Finally, Parametric Portfolio Associates LLC grew its stake in Aetna by 63.7% in the 2nd quarter. Parametric Portfolio Associates LLC now owns 1,113,972 shares of the company’s stock valued at $169,134,000 after buying an additional 433,372 shares during the last quarter. Institutional investors own 87.69% of the company’s stock.
Shares of Aetna Inc (NYSE:AET) opened at $187.80 on Friday. The company has a quick ratio of 0.53, a current ratio of 0.53 and a debt-to-equity ratio of 0.52. Aetna Inc has a 1-year low of $116.04 and a 1-year high of $192.37. The firm has a market cap of $60,501.70, a price-to-earnings ratio of 34.78, a price-to-earnings-growth ratio of 1.59 and a beta of 0.61.
Aetna (NYSE:AET) last issued its quarterly earnings results on Tuesday, October 31st. The company reported $2.45 earnings per share for the quarter, beating analysts’ consensus estimates of $2.06 by $0.39. Aetna had a net margin of 2.93% and a return on equity of 21.84%. The firm had revenue of $14.99 billion during the quarter, compared to the consensus estimate of $15.12 billion. During the same period in the prior year, the firm earned $2.07 EPS. The business’s revenue was down 5.0% on a year-over-year basis. equities research analysts predict that Aetna Inc will post 9.78 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Thursday, January 11th will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 1.06%. The ex-dividend date is Wednesday, January 10th. Aetna’s dividend payout ratio (DPR) is presently 37.04%.
AET has been the topic of a number of research analyst reports. Piper Jaffray Companies reiterated a “hold” rating and issued a $187.00 target price on shares of Aetna in a research note on Friday, November 3rd. Zacks Investment Research lowered shares of Aetna from a “buy” rating to a “hold” rating in a research note on Thursday, November 2nd. Argus lowered shares of Aetna from a “buy” rating to a “hold” rating and set a $185.00 target price on the stock. in a research note on Wednesday, December 6th. BMO Capital Markets raised their target price on shares of Aetna from $175.00 to $200.00 and gave the company a “market perform” rating in a research note on Friday, October 27th. Finally, Cantor Fitzgerald lowered shares of Aetna from an “overweight” rating to a “neutral” rating in a research note on Thursday, October 26th. Twelve equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. The company has an average rating of “Buy” and an average price target of $172.64.
ILLEGAL ACTIVITY NOTICE: “Westpac Banking Corp Has $8.48 Million Stake in Aetna Inc (AET)” was published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece on another publication, it was copied illegally and republished in violation of U.S. & international trademark and copyright legislation. The legal version of this piece can be viewed at https://www.dispatchtribunal.com/2018/01/20/westpac-banking-corp-has-8-48-million-stake-in-aetna-inc-aet.html.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.